Logo

Indo US Bio-Tech Share Price

Indo US Bio-Tech (INR)245.9-8.9   (-3.5%)

Exchange ScripsBSE541304NSEINDOUSISININE250Z01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Indo US Bio-Tech Performance

Market performance
Open price257.6
High257.6
Volumes3446
Prev Close245.9
Low244.05
Closing date2025-01-10
Historical performance
1 Year High388.40
3 Year High388.40
5 Year High388.40
1 Year Low222.00
3 Year Low222.00
5 Year Low222.00

Indo US Bio-Tech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
490
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
89.04
Dividend Yield
Dividend Yield
N/A

Indo US Bio-Tech Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Indo US Bio-Tech Technicals

IndicatorsValueSignal
5-DMA262.04Bearish
10-DMA280.62Bearish
20-DMA304Bearish
50-DMA285.97Bearish
100-DMA
200-DMA

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters77775
Foreign Investors---------------
Domestic Investors77775
Public Investors2821964112611591222
Government---------------

Indo US Bio-Tech Financials

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Other Income2------
Operating Profit705440
Interest12129
Depreciation432
Profit Before Tax533929
Consolidated Net Profit514925
Adjusted EPS332

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Share Capital926161
Total Reserves293153104
Minority Interest---------
Total Non-Current Liabilities444015
Total Liabilities552434347
Capital Work in Progress232013
Total Assets552434347

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2022Mar-2021Mar-2020
Cash Flow from Operating Activities272-8
Cash Flow from Investing Activities-54-18-6
Cash Flow from Financing Activitie271615
Net Cash Inflow / Outflow-1-11
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 89.04.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 1.5.
  • In the last financial year, the company had an EBITDA of ₹70 Million.
  • The company generated revenue of ₹501 Million in the previous financial year.

Indo US Bio-Tech

245.9-8.9   (-3.5%)

Investment Amount: ₹ 29260
Current Value: ₹ 24590
Performance: -16%
P/L: ₹ -4670
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Narmada Agrobase

30.5

21.34

December 12 - January 12

Mangalam Global Ent

21

28.61

December 12 - January 12

Harrisons Malayalam

3.9

284.45

December 12 - January 12

Kaveri Seed

-4.1

908.5

December 12 - January 12

Venkys India

-6.6

1701.85

December 12 - January 12

Agri-Tech (India)

-9.3

185.48

December 12 - January 12

Bombay Super Hybrid

-12.2

141.45

December 12 - January 12

Nath Bio-Genes

-15.1

172.87

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month